Structure oral GLP-1 shows 44-week obesity data
4 articles curated from biotech news
44-week data bolster best-in-class case for Structure’s obesity pill
BioCenturyMar 16, 2026Structure’s GLP-1 pill shows ‘best-in-class’ potential in obesity trial
BioPharma DiveMar 16, 2026Structure Climbs on ‘Highly Competitive’ Profile for Weight Loss Pill
BioSpaceMar 16, 2026STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
STAT NewsMar 16, 2026
Want daily biotech news like this? Sign up free